Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial: a Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
Status: Enrolling
Updated:  1/7/2016
Aetna Inc
mi
from
Hartford, CT
A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial: a Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
Status: Enrolling
Updated: 1/7/2016
Aetna Inc
mi
from
Hartford, CT
Click here to add this to my saved trials
Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery
A Prospective, Non-randomized, Two Arm, Multi-center Clinical Trial to Evaluate the Safety and Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System and the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.
Status: Enrolling
Updated:  1/8/2016
Abbott Vascular
mi
from
Santa Clara, CA
Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery
A Prospective, Non-randomized, Two Arm, Multi-center Clinical Trial to Evaluate the Safety and Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System and the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.
Status: Enrolling
Updated: 1/8/2016
Abbott Vascular
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter
Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter
Status: Enrolling
Updated:  1/9/2016
Dallas VA Medical Center
mi
from
Dallas, TX
Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter
Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter
Status: Enrolling
Updated: 1/9/2016
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Alcohol and Atherosclerosis Pilot Study
Alcohol and Atherosclerosis Pilot Study
Status: Enrolling
Updated:  1/11/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Alcohol and Atherosclerosis Pilot Study
Alcohol and Atherosclerosis Pilot Study
Status: Enrolling
Updated: 1/11/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Trial of a Silver Eluting Dressing System
Prospective, Randomized Clinical Trial of a Silver Eluting Dressing System for Prevention of Lower Extremity Revascularization Wound Complications
Status: Enrolling
Updated:  1/11/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Clinical Trial of a Silver Eluting Dressing System
Prospective, Randomized Clinical Trial of a Silver Eluting Dressing System for Prevention of Lower Extremity Revascularization Wound Complications
Status: Enrolling
Updated: 1/11/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Trial of a Silver Eluting Dressing System
Prospective, Randomized Clinical Trial of a Silver Eluting Dressing System for Prevention of Lower Extremity Revascularization Wound Complications
Status: Enrolling
Updated:  1/11/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Clinical Trial of a Silver Eluting Dressing System
Prospective, Randomized Clinical Trial of a Silver Eluting Dressing System for Prevention of Lower Extremity Revascularization Wound Complications
Status: Enrolling
Updated: 1/11/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Trial of a Silver Eluting Dressing System
Prospective, Randomized Clinical Trial of a Silver Eluting Dressing System for Prevention of Lower Extremity Revascularization Wound Complications
Status: Enrolling
Updated:  1/11/2016
Michael Debakey Veterans Affairs Medical Center
mi
from
Houston, TX
Clinical Trial of a Silver Eluting Dressing System
Prospective, Randomized Clinical Trial of a Silver Eluting Dressing System for Prevention of Lower Extremity Revascularization Wound Complications
Status: Enrolling
Updated: 1/11/2016
Michael Debakey Veterans Affairs Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Fitness, Cellular Aging, and Caregiver Stress Study
The Effects of Exercise and Life Stress on Telomere Maintenance and Cardiovascular Disease Risk
Status: Enrolling
Updated:  1/11/2016
University of California at San Francisco
mi
from
San Francisco, CA
Fitness, Cellular Aging, and Caregiver Stress Study
The Effects of Exercise and Life Stress on Telomere Maintenance and Cardiovascular Disease Risk
Status: Enrolling
Updated: 1/11/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protection
Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protection
Status: Enrolling
Updated:  1/11/2016
University of Illinois at Chicago
mi
from
Chicago, IL
Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protection
Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protection
Status: Enrolling
Updated: 1/11/2016
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation
Investigation of the Effect of Nitric Oxide on Ischemic Reperfusion Injury During Extended Donor Criteria Liver Transplantation
Status: Enrolling
Updated:  1/13/2016
University of Colorado Hospital
mi
from
Aurora, CO
Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation
Investigation of the Effect of Nitric Oxide on Ischemic Reperfusion Injury During Extended Donor Criteria Liver Transplantation
Status: Enrolling
Updated: 1/13/2016
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Role of Vitamin D in Secondary Prevention of Cardiovascular Events
Role of Vitamin D in Secondary Prevention of Cardiovascular Events
Status: Enrolling
Updated:  1/14/2016
The Cardiac Center at Creighton University
mi
from
Omaha, NE
Role of Vitamin D in Secondary Prevention of Cardiovascular Events
Role of Vitamin D in Secondary Prevention of Cardiovascular Events
Status: Enrolling
Updated: 1/14/2016
The Cardiac Center at Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Role of Vitamin D in Secondary Prevention of Cardiovascular Events
Role of Vitamin D in Secondary Prevention of Cardiovascular Events
Status: Enrolling
Updated:  1/14/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Role of Vitamin D in Secondary Prevention of Cardiovascular Events
Role of Vitamin D in Secondary Prevention of Cardiovascular Events
Status: Enrolling
Updated: 1/14/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing
An In-state Multi-center Evaluation of Treadmill Exercise Stress Cardiac Magnetic Resonance
Status: Enrolling
Updated:  1/15/2016
The Lindner Center at The Christ Hospital
mi
from
Cinncinatti, OH
Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing
An In-state Multi-center Evaluation of Treadmill Exercise Stress Cardiac Magnetic Resonance
Status: Enrolling
Updated: 1/15/2016
The Lindner Center at The Christ Hospital
mi
from
Cinncinatti, OH
Click here to add this to my saved trials
Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing
An In-state Multi-center Evaluation of Treadmill Exercise Stress Cardiac Magnetic Resonance
Status: Enrolling
Updated:  1/15/2016
Ohio State University
mi
from
Columbus, OH
Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing
An In-state Multi-center Evaluation of Treadmill Exercise Stress Cardiac Magnetic Resonance
Status: Enrolling
Updated: 1/15/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing
An In-state Multi-center Evaluation of Treadmill Exercise Stress Cardiac Magnetic Resonance
Status: Enrolling
Updated:  1/15/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing
An In-state Multi-center Evaluation of Treadmill Exercise Stress Cardiac Magnetic Resonance
Status: Enrolling
Updated: 1/15/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The Medtronic RESOLUTE US Clinical Trial
A Clinical Evaluation of the Medtronic Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries With a Reference Vessel Diameter of 2.25 mm to 4.2mm
Status: Enrolling
Updated:  1/20/2016
East Texas Medical Center
mi
from
Tyler, TX
The Medtronic RESOLUTE US Clinical Trial
A Clinical Evaluation of the Medtronic Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries With a Reference Vessel Diameter of 2.25 mm to 4.2mm
Status: Enrolling
Updated: 1/20/2016
East Texas Medical Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Remote Ischemic Preconditioning Prior to Vascular Surgery
Cardiac Remote Ischemic Preconditioning Prior to Elective Major Vascular Surgery
Status: Enrolling
Updated:  1/20/2016
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
Remote Ischemic Preconditioning Prior to Vascular Surgery
Cardiac Remote Ischemic Preconditioning Prior to Elective Major Vascular Surgery
Status: Enrolling
Updated: 1/20/2016
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke
Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke
Status: Enrolling
Updated:  1/20/2016
University of California, Irvine Medical Center
mi
from
Orange, CA
Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke
Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke
Status: Enrolling
Updated: 1/20/2016
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Effects of Polyphenolic-rich Dark Chocolate/Cocoa and Almonds on Cardiovascular Disease Risk Factors
Effects of Polyphenolic-rich Dark Chocolate/Cocoa and Almonds on Cardiovascular Disease Risk Factors
Status: Enrolling
Updated:  1/20/2016
Penn State Clinical Research Center, Noll Lab
mi
from
University Park, PA
Effects of Polyphenolic-rich Dark Chocolate/Cocoa and Almonds on Cardiovascular Disease Risk Factors
Effects of Polyphenolic-rich Dark Chocolate/Cocoa and Almonds on Cardiovascular Disease Risk Factors
Status: Enrolling
Updated: 1/20/2016
Penn State Clinical Research Center, Noll Lab
mi
from
University Park, PA
Click here to add this to my saved trials
Genetics of Peripheral Artery Genomics
Genetics of Peripheral Artery Disease
Status: Enrolling
Updated:  1/21/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Genetics of Peripheral Artery Genomics
Genetics of Peripheral Artery Disease
Status: Enrolling
Updated: 1/21/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia
Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia: The FFAME Study
Status: Enrolling
Updated:  1/21/2016
Clinical and Translational Research Center (CTRC); Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia
Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia: The FFAME Study
Status: Enrolling
Updated: 1/21/2016
Clinical and Translational Research Center (CTRC); Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Spain REhabilitation Center
mi
from
Birmingham, AL
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Spain REhabilitation Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Kirklin Clinic
mi
from
Birmingham, AL
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Kirklin Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
University Hospital
mi
from
Birmingham, AL
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
University Hospital
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Broward Health North
mi
from
Deerfield Beach, FL
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Broward Health North
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Neurologic Consultant, P.A.
mi
from
Fort Lauderdale, FL
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Neurologic Consultant, P.A.
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Fawcett Memorial Hospital
mi
from
Port Charlotte, FL
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Fawcett Memorial Hospital
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Neurostudies, Inc.
mi
from
Port Charlotte, FL
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Neurostudies, Inc.
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Jagdish Sidhpura M.D.
mi
from
Columbus, GA
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Jagdish Sidhpura M.D.
mi
from
Columbus, GA
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Jose Canedo, M.D., West Georgia Neurology
mi
from
Columbus, GA
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Jose Canedo, M.D., West Georgia Neurology
mi
from
Columbus, GA
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
St. Francis Hospital
mi
from
Columbus, GA
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
St. Francis Hospital
mi
from
Columbus, GA
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Muscogee Manor & Rehabilitation Center
mi
from
Columbus, GA
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Muscogee Manor & Rehabilitation Center
mi
from
Columbus, GA
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Medical Research and Health Education Foundation, Inc.
mi
from
Columbus, GA
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Medical Research and Health Education Foundation, Inc.
mi
from
Columbus, GA
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Parkview Hospital Randallia
mi
from
Fort Wayne, IN
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Parkview Hospital Randallia
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Fort Wayne Neurological Center
mi
from
Fort Wayne, IN
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Fort Wayne Neurological Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Parkview Regional Medical Center
mi
from
Fort Wayne, IN
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Parkview Regional Medical Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Parkview Research Center
mi
from
Fort Wayne, IN
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Parkview Research Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Norwood Nursing Center
mi
from
Huntington, IN
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Norwood Nursing Center
mi
from
Huntington, IN
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Massachusetts General Hospital/Department of Neurology
mi
from
Boston, MA
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Massachusetts General Hospital/Department of Neurology
mi
from
Boston, MA
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Wayne State University
mi
from
Detroit, MI
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Barnes Jewish Hospital
mi
from
St. Louis, MO
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Rehabilitation Institute of St. Louis
mi
from
St. Louis, MO
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Rehabilitation Institute of St. Louis
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
UNC Healthcare
mi
from
Chapel Hill, NC
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
UNC Healthcare
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
UNC Department of Neurology Stroke Division
mi
from
Chapel Hill, NC
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
UNC Department of Neurology Stroke Division
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Investigational Drug Services at OU Medical Center
mi
from
Oklahoma City, OK
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Investigational Drug Services at OU Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Oklahoma University Health Sciences Center
mi
from
Oklahoma City, OK
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Oklahoma University Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
OU Medical Center
mi
from
Oklahoma City, OK
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
OU Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
OU Physician's Building
mi
from
Oklahoma City, OK
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
OU Physician's Building
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated:  1/22/2016
Penn State Milton South Hershey Medical Center / Penn State College of Medicine
mi
from
Hershey, PA
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of Pf-03049423 In Subjects With Ischemic Stroke
Status: Enrolling
Updated: 1/22/2016
Penn State Milton South Hershey Medical Center / Penn State College of Medicine
mi
from
Hershey, PA
Click here to add this to my saved trials